Impact of Baseline GLP-1 Receptor Agonist Use on Albuminuria Reduction and Safety With Simultaneous Initiation of Finerenone and Empagliflozin in Type 2 Diabetes and Chronic Kidney Disease (CONFIDENCE Trial)
In CONFIDENCE, simultaneous initiation with finerenone and an SGLT2 inhibitor was effective and well tolerated compared with monotherapy, irrespective of background use of a GLP-1 RA.
Authors
- Amy K. Mottl (ORCID: https://orcid.org/0000-0002-4258-1726)
- Jennifer B. Green (ORCID: https://orcid.org/0000-0002-9967-5352)
- Hiddo J.L. Heerspink (ORCID: https://orcid.org/0000-0002-3126-3730)
- Masaomi Nangaku (ORCID: https://orcid.org/0000-0001-7401-2934)
- Katja Rohwedder
- Johannes F.E. Mann (ORCID: https://orcid.org/0000-0002-3154-5332)
- Julio Rosenstock (ORCID: https://orcid.org/0000-0001-8324-3275)
- Janet B. McGill (ORCID: https://orcid.org/0000-0002-6228-6521)
- Rajiv Agarwal (ORCID: https://orcid.org/0000-0001-8355-7100)
- Meike Brinker (ORCID: https://orcid.org/0000-0002-1560-9535)
- Charlie Scott (ORCID: https://orcid.org/0000-0002-2816-4889)
- Muthiah Vaduganathan (ORCID: https://orcid.org/0000-0003-0885-1953)
- Peter R Rossing (ORCID: https://orcid.org/0000-0002-1531-4294)
- Li Li (ORCID: https://orcid.org/0000-0003-0897-5374)
- Na Li (ORCID: https://orcid.org/0000-0001-6361-8463)
Institutions
- University of North Carolina at Chapel Hill (US)
- University of Copenhagen (DK)
- Brigham and Women's Hospital (US)
- University Medical Center Groningen (NL)
- Steno Diabetes Centers (DK)
- University of Indianapolis (US)
- Harvard University (US)
- Bayer (United States) (US)
- Duke University (US)
- Friedrich-Alexander-Universität Erlangen-Nürnberg (DE)
- Washington University in St. Louis (US)
- Medical City Dallas Hospital (US)
- Clinical Research Institute (US)
- Arbeitsgemeinschaft Gynäkologische Onkologie Studiengruppe (DE)
- EP Analytics (United States) (US)
- University of Tokyo Hospital (JP)
- Richard L. Roudebush VA Medical Center (US)
- Velocity Clinical Research (United States) (US)
- Danish Diabetes Association (DK)
- Kidney Centre (PK)
- Beijing Chaoyang Emergency Medical Center (CN)
- Indiana University School of Medicine
- Indiana University – Purdue University Indianapolis (US)
- Bayer (Germany) (DE)
- The University of Tokyo (JP)
- IT University of Copenhagen (DK)
Publication Details
- Journal
- Diabetes Care
- Published
- 2025-09-19
- DOI
- https://doi.org/10.2337/dc25-1673
- Citations
- 4
- Primary Topic
- Hormonal Regulation and Hypertension
- Type
- article
- Field-Weighted Citation Impact
- 5.18